JG
OSIR

Jefferies Group’s Osiris Therapeutics, Inc. Common Stock OSIR Stock Holding History

Jefferies Group’s Portfolio OSIR Stock Details OSIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-8,700
Closed -$140K – 2665
2013
Q4 		$140K Sell
8,700
-3,000
-26% -$47.8K ﹤0.01% 1665
2013
Q3 		$195K Buy
+11,700
New +$173K ﹤0.01% 1621

Other funds holding OSIR

FGAM
Financial Gravity Asset Management Lakeway, Texas $562M AUM

Jefferies Group's OSIR Position: Q2 2019 in Review

Jefferies Group sold out of Osiris Therapeutics, Inc. Common Stock (OSIR) in Q2 2019, closing a stake of 68,678 shares — an estimated $1.3M sold.

Jefferies Group first reported a position in OSIR in Q3 2013 and held it in 5 quarters. The position peaked at $1.3M in Q1 2019. 1 fund tracked by Wall St. Rank holds OSIR as of Q2 2019.

  • Jefferies Group reported no remaining Osiris Therapeutics, Inc. Common Stock position as of Q2 2019 after selling out during the quarter.
  • Jefferies Group sold 68,678 Osiris Therapeutics, Inc. Common Stock shares in Q2 2019, an estimated $1.3M.
  • Jefferies Group first reported a position in Osiris Therapeutics, Inc. Common Stock in Q3 2013 and held it in 5 quarters.
  • Jefferies Group's Osiris Therapeutics, Inc. Common Stock position peaked at $1.3M in Q1 2019.
  • 1 fund tracked by Wall St. Rank held Osiris Therapeutics, Inc. Common Stock as of Q2 2019.

Based on Jefferies Group's 13F filing for Q2 2019, filed 14 Aug 2019.